|
|
Article: FDA Clears SPORANOX(R) Oral Solution for Oral and Esophageal Fungal Infections
- Article from:
- PR Newswire
- Article date:
- March 3, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
TITUSVILLE, N.J., March 3 /PRNewswire/ -- The Food and Drug Administration has cleared a new medication, SPORANOX(R) (itraconazole) Oral Solution, for the treatment of painful and debilitating fungal infections of the esophagus or the mouth, commonly called thrush. Thrush affects nearly half of all HIV-positive individuals and up to 95% of patients with AIDS.
Oral and esophageal candidiasis cause painful sores in the mouth or esophagus, often causing great difficulty eating or taking medication, and leading to nutritional deficits and weight loss.
In clinical studies, SPORANOX(R) Oral Solution was as effective as current front-line therapy in ...